| Symbol | CAPR |
|---|---|
| Name | CAPRICOR THERAPEUTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 10865 ROAD TO THE CURE,SUITE 150, SAN DIEGO, California, 92121, United States |
| Telephone | 858-727-1755 |
| Fax | — |
| — | |
| Website | https://www.capricor.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricors lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricors proprietary StealthX exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. Additional info from NASDAQ: |
Krasney Karen 🟡 adjusted position in 25.0K shares (1 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $31.70 Transaction Date: May 01, 2026 | Filing ID: 000008
Read moreBergmann Anthony 🟡 adjusted position in 25.0K shares (1 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $31.70 Transaction Date: May 01, 2026 | Filing ID: 000007
Read moreCapricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
Read moreNew Form ARS - CAPRICOR THERAPEUTICS, INC. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001104659-26-042117 <b>Size:</b> 2 MB
Read moreNew Form DEF 14A - CAPRICOR THERAPEUTICS, INC. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001104659-26-042070 <b>Size:</b> 2 MB
Read moreSabar Karimah Es 🟡 adjusted position in 7.5K shares (1 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $32.00 Transaction Date: Apr 02, 2026 | Filing ID: 000006
Read more📋 Karimah Es Sabar (Director) plans to sell 8K shares of CAPRICOR THERAPEUTICS INC (at $30.12 each, total $227K) Filed: Apr 02, 2026 | ID: 003211
Read moreKrasney Karen 🟡 adjusted position in 25.0K shares (3 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $30.12 Transaction Date: Mar 31, 2026 | Filing ID: 000006
Read moreSabar Karimah Es 🟡 adjusted position in 115.0K shares (2 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $31.03 ($4.6M) Transaction Date: Mar 31, 2026 | Filing ID: 000004
Read moreBergmann Anthony 🟡 adjusted position in 25.0K shares (1 derivative) of CAPRICOR THERAPEUTICS, INC. (CAPR) at $30.13 Transaction Date: Mar 31, 2026 | Filing ID: 000005
Read more